100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Test Bank for Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2023), Chapter 1-58 | All Chapters with Correct Questions and Answers/A+ $14.99   Add to cart

Exam (elaborations)

Test Bank for Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2023), Chapter 1-58 | All Chapters with Correct Questions and Answers/A+

 2 views  0 purchase
  • Course
  • Lilleys Pharmacology for Canadian Healthcare
  • Institution
  • Lilleys Pharmacology For Canadian Healthcare

Test Bank for Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2023), Chapter 1-58 | All Chapters with Correct Questions and Answers/A+

Preview 10 out of 313  pages

  • March 3, 2024
  • 313
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
  • Lilleys Pharmacology for Canadian Healthcare
  • Lilleys Pharmacology for Canadian Healthcare
avatar-seller
SOLUTIONS002
lOMoARcPSD|62 2916

,Table of Content
Chapter 01: The Nursing Process and Drug Therapy Lilley: Pharmacology and the Nursing
Process, 9th Edition ........................................................................................................................ 5
Chapter 02: Pharmacologic Principles............................................................................................ 9
Chapter 03: Lifespan Considerations............................................................................................ 15
Chapter 04: Cultural, Legal, and Ethical Considerations Lilley: Pharmacology and the Nursing
Process, 9th Edition ...................................................................................................................... 21
Chapter 05: Medication Errors: Preventing and Responding Lilley: Pharmacology and the
Nursing Process, 9th Edition ........................................................................................................ 27
Chapter 06: Patient Education and Drug Therapy ........................................................................ 31
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements Lilley: Pharmacology
and the Nursing Process, 9th Edition............................................................................................ 36
Chapter 08: Gene Therapy and Pharmacogenomics ..................................................................... 40
Chapter 09: Photo Atlas of Drug Administration ......................................................................... 44
Chapter 10: Analgesic Drugs ........................................................................................................ 52
Chapter 11: General and Local Anesthetics ................................................................................. 59
Chapter 12: Central Nervous System Depressants and Muscle Relaxants Lilley: Pharmacology
and the Nursing Process, 9th Edition............................................................................................ 63
Chapter 13: Central Nervous System Stimulants and Related Drugs Lilley: Pharmacology and
the Nursing Process, 9th Edition .................................................................................................. 68
Chapter 14: Antiepileptic Drugs ................................................................................................... 72
Chapter 15: Antiparkinson Drugs ................................................................................................. 77
Chapter 16: Psychotherapeutic Drugs .......................................................................................... 82
Chapter 17: Substance Use Disorder ............................................................................................ 89
Chapter 18: Adrenergic Drugs ...................................................................................................... 94
Chapter 19: Adrenergic-Blocking Drugs ...................................................................................... 99
Chapter 20: Cholinergic Drugs ................................................................................................... 104
Chapter 21: Cholinergic-Blocking Drugs ................................................................................... 109
Chapter 22: Antihypertensive Drugs .......................................................................................... 114
Chapter 23: Antianginal Drugs ................................................................................................... 120
Chapter 24: Heart Failure Drugs................................................................................................. 126
Chapter 25: Antidysrhythmic Drugs ........................................................................................... 131
Chapter 26: Coagulation Modifier Drugs ................................................................................... 136
Chapter 27: Antilipemic Drugs ................................................................................................... 142
Chapter 28: Diuretic Drugs......................................................................................................... 147
Chapter 29: Fluids and Electrolytes ............................................................................................ 153
Chapter 30: Pituitary Drugs ........................................................................................................ 159
Chapter 31: Thyroid and Antithyroid Drugs .............................................................................. 163
Chapter 32: Antidiabetic Drugs .................................................................................................. 168
Chapter 33: Adrenal Drugs ......................................................................................................... 176
Chapter 34: Women’s Health Drugs........................................................................................... 180
Chapter 35: Men’s Health Drugs ................................................................................................ 187
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants Lilley:

,Pharmacology and the Nursing Process, 9th Edition.................................................................. 191
Chapter 37: Respiratory Drugs ................................................................................................... 196
Chapter 38: Antibiotics Part 1 .................................................................................................... 201
Chapter 39: Antibiotics Part 2 .................................................................................................... 208
Chapter 40: Antiviral Drugs ....................................................................................................... 213
Chapter 41: Antitubercular Drugs .............................................................................................. 218
Chapter 42: Antifungal Drugs .................................................................................................... 223
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs Lilley: Pharmacology and the
Nursing Process, 9th Edition ...................................................................................................... 228
Chapter 44: Anti-inflammatory and Antigout Drugs Lilley: Pharmacology and the Nursing
Process, 9th Edition .................................................................................................................... 233
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific Drugs .... 238
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous
Drugs .......................................................................................................................................... 244
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs Lilley: Pharmacology and
the Nursing Process, 9th Edition ................................................................................................ 249
Chapter 48: Immunosuppressant Drugs...................................................................................... 254
Chapter 49: Immunizing Drugs .................................................................................................. 259
Chapter 50: Acid-Controlling Drugs .......................................................................................... 265
Chapter 51: Bowel Disorder Drugs ............................................................................................ 271
Chapter 52: Antiemetic and Antinausea Drugs .......................................................................... 278
Chapter 53: Vitamins and Minerals ............................................................................................ 283
Chapter 54: Anemia Drugs ......................................................................................................... 289
Chapter 55: Nutritional Supplements ......................................................................................... 295
Chapter 56: Dermatologic Drugs ................................................................................................ 299
Chapter 57: Ophthalmic Drugs ................................................................................................... 305
Chapter 58: Otic Drugs ............................................................................................................... 310

,
,Chapter 01: The Nursing Process and Drug Therapy Lilley:
Pharmacology and the Nursing Process, 9th Edition


MULTIPLE CHOICE

1. The nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. Identification of human needs statements occur with which of these
activities?
a. Collection of patient data
b. Administering interventions
c. Deciding on patient outcomes
d. Documenting the patient’s behavior
ANS: A
Identification of human needs occurs with the collection of patient data.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was
busy and gave the medication 2 hours after the scheduled dose was due. What type of
problem does this represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
ANS: A
“Right time” is correct because the medication was given more than 30 minutes after the
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route is not
affected. “Medication” is incorrect because the medication ordered will not change.

DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control

3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first
dose and documenting the patient’s therapeutic response to the medication. Which phase
of the nursing process do these actions illustrate?
a. Human needs statement
b. Planning
c. Implementation
d. Evaluation
ANS: D
Monitoring the patient’s progress, including the patient’s response to the medication, is
part of the evaluation phase. Planning, implementation, and human needs statement are not
illustrated by this example.




Chapter 1 - The Nursing Process and Drug Therapy 3

, DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process:
Evaluation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus.
Which statement best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient will adhere to the new insulin treatment regimen.
d. The patient will demonstrate correct blood glucose testing technique.
ANS: D
“Demonstrating correct blood glucose testing technique” is a specific and measurable
outcome criterion. “Following instructions” and “not experiencing complications” are not
specific criteria. “Adhering to new regimen” would be difficult to measure.

DIF: Cognitive Level: Applying (Application) TOP: Nursing Process:
Planning
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

5. Which activity best reflects the implementation phase of the nursing process for the patient
who is newly diagnosed with hypertension?
a. Providing education on keeping a journal of blood pressure readings
b. Setting goals and outcome criteria with the patient’s input
c. Recording a drug history regarding over-the-counter medications used at home
d. Formulating human needs statements regarding insufficient knowledge related to
the new treatment regimen
ANS: A
Education is an intervention that occurs during the implementation phase. Setting goals
and outcomes reflects the planning phase. Recording a drug history reflects the assessment
phase. Formulating human needs statements reflects analysis of data as part of planning.

DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

6. The medication order reads, “Give ondansetron (Zofran) 4 mg, 30 minutes before
beginning chemotherapy to prevent nausea.” The nurse notes that the route is missing from
the order. What is the nurse’s best action?
a. Give the medication intravenously because the patient might vomit.
b. Give the medication orally because the tablets are available in 4-mg doses.
c. Contact the prescriber to clarify the route of the medication ordered.
d. Hold the medication until the prescriber returns to make rounds.
ANS: C
A complete medication order includes the route of administration. If a medication order
does not include the route, the nurse must ask the prescriber to clarify it. The intravenous
and oral routes are not interchangeable. Holding the medication until the prescriber returns
would mean that the patient would not receive a needed medication.

DIF: Cognitive Level: Applying (Application)




Chapter 1 - The Nursing Process and Drug Therapy 4

, TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

7. When the nurse considers the timing of a drug dose, which factor is appropriate to
consider when deciding when to give a drug?
a. The patient’s ability to swallow
b. The patient’s height
c. The patient’s last meal
d. The patient’s allergies
ANS: C
The nurse must consider specific pharmacokinetic/pharmacodynamic drug properties that
may be affected by the timing of the last meal. The patient’s ability to swallow, height,
and allergies are not factors to consider regarding the timing of the drug’s administration.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care

8. The nurse is performing an assessment of a newly admitted patient. Which is an example
of subjective data?
a. Blood pressure 158/96 mm Hg
b. Weight 255 pounds
c. The patient reports that he uses the herbal product ginkgo.
d. The patient’s complete blood count results.
ANS: C
Subjective data include information shared through the spoken word by any reliable
source, such as the patient. Objective data may be defined as any information gathered
through the senses or that which is seen, heard, felt, or smelled. A patient’s blood pressure,
weight, and laboratory tests are all examples of objective data.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe and Effective Care Environment: Management of Care


MULTIPLE RESPONSE

1. When giving medications, the nurse will follow the rights of medication administration.
The rights include the right documentation, the right reason, the right response, and the
patient’s right to refuse. Which of these are additional rights? (Select all that apply.)
a. Right drug
b. Right route
c. Right dose
d. Right diagnosis
e. Right time
f. Right patient
ANS: A, B, C, E, F
Additional rights of medication administration must always include the right drug, right
dose, right time, right route, and right patient. The right diagnosis is incorrect.




Chapter 1 - The Nursing Process and Drug Therapy 5

, DIF: Cognitive Level: Remembering (Knowledge)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control

2. Place the phases of the nursing process in the correct order, with 1 as the first phase and 5
as the last phase. (Select all that apply.)
a. Planning
b. Evaluation
c. Assessment
d. Implementation
e. Human needs statement
ANS: A, B, C, D, E
The nursing process is an ongoing process that begins with assessing and continues with
human needs statement, planning, implementing, and evaluating.

DIF: Cognitive Level: Applying (Application) TOP: Nursing Process:
General
MSC: NCLEX: Safe and Effective Care Environment: Management of Care




Chapter 1 - The Nursing Process and Drug Therapy 6

,Chapter 02: Pharmacologic Principles
Lilley: Pharmacology and the Nursing Process, 9th Edition


MULTIPLE CHOICE

1. The patient is receiving two different drugs. At current dosages and dosage forms, both
drugs have the same concentration of the active ingredient. Which term is used to identify
this principle?
a. Bioequivalent
b. Synergistic
c. Prodrugs
d. Steady state
ANS: A
Two drugs absorbed into the circulation in the same amount (in specific dosage forms)
have the same bioavailability; thus, they are bioequivalent. A drug’s steady state is the
physiologic state in which the amount of drug removed via elimination is equal to the
amount of drug absorbed from each dose. The term synergistic refers to two drugs, given
together, with a resulting effect that is greater than the sum of the effects of each drug
given alone. A prodrug is an inactive drug dosage form that is converted to an active
metabolite by various biochemical reactions once it is inside the body.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

2. When given an intravenous medication, the patient says to the nurse, “I usually take pills.
Why does this medication have to be given in the arm?” What is the nurse’s best answer?
a. “The medication will cause fewer adverse effects when given intravenously.”
b. “The intravenous medication will have delayed absorption into the body’s tissues.”
c. “The action of the medication will begin sooner when given intravenously.”
d. “There is a lower chance of allergic reactions when drugs are given intravenously.”
ANS: C
An intravenous (IV) injection provides the fastest route of absorption. The IV route does
not affect the number of adverse effects, nor does it cause delayed tissue absorption (it
results in faster absorption). The IV route does not affect the number of allergic reactions.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Implementation
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

3. The nurse is administering parenteral drugs. Which statement is true regarding parenteral
drugs?
a. Parenteral drugs bypass the first-pass effect.
b. Absorption of parenteral drugs is affected by reduced blood flow to the stomach.
c. Absorption of parenteral drugs is faster when the stomach is empty.
d. Parenteral drugs exert their effects while circulating in the bloodstream.
ANS: A

, Drugs given by the parenteral route bypass the first-pass effect. Reduced blood flow to the
stomach and the presence of food in the stomach apply to enteral drugs (taken orally), not
to parenteral drugs. Parenteral drugs must be absorbed into cells and tissues from the
circulation before they can exert their effects; they do not exert their effects while
circulating in the bloodstream.

DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process:
General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

4. When monitoring the patient receiving an intravenous infusion to reduce blood pressure,
the nurse notes that the patient’s blood pressure is extremely low, and the patient is
lethargic and difficult to awaken. This would be classified as which type of adverse drug
reaction?
a. Adverse effect
b. Allergic reaction
c. Idiosyncratic reaction
d. Pharmacologic reaction
ANS: D
A pharmacologic reaction is an extension of a drug’s normal effects in the body. In this
case, the antihypertensive drug lowered the patient’s blood pressure levels too much. The
other options do not describe a pharmacologic reaction. An adverse effect is a predictable,
well-known adverse drug reaction that results in minor or no changes in patient
management. An allergic reaction (also known as a hypersensitivity reaction) involves the
patient’s immune system. An idiosyncratic reaction is unexpected and is defined as a
genetically determined abnormal response to normal dosages of a drug.

DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process:
General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

5. The nurse is reviewing pharmacology terms for a group of newly graduated nurses. Which
sentence defines a drug’s half-life?
a. The time it takes for the drug to cause half of its therapeutic response
b. The time it takes for one half of the original amount of a drug to reach the target
cells
c. The time it takes for one half of the original amount of a drug to be removed from
the body
d. The time it takes for one half of the original amount of a drug to be absorbed into
the circulation
ANS: C
A drug’s half-life is the time it takes for one half of the original amount of a drug to be
removed from the body. It is a measure of the rate at which drugs are removed from the
body. The other options are incorrect definitions of half-life.

DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process:
General
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies




Chapter 2 - Pharmacologic Principles 8

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller SOLUTIONS002. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $14.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

79064 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$14.99
  • (0)
  Add to cart